Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105732373A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105732373A details high-purity (R)-HPBE production via enzymatic reduction. This method offers significant supply chain and cost advantages for pharmaceutical intermediates manufacturing.